Kinetics of pDCs, mDCs, γδT cells and regulatory T cells in association with graft versus host disease after hematopoietic stem cell transplantation

International Journal of Laboratory Hematology

Volumn 33, Issue 4, 2011, Pages 378-390

  Watanabe, N ^a,b   Narita, M ^a   Furukawa, T ^c   Nakamura, T ^a   Yamahira, A ^a   Masuko, M ^b   Toba, K ^b   Fuse, I ^a   Aizawa, Y ^b   Takahashi, M ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

BMT; Flow cytometry; GVHD; Immunocompetent cells

Indexed keywords

CYCLOSPORIN A; METHOTREXATE; METHYLPREDNISOLONE; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOGRAFT; APLASTIC ANEMIA; ARTICLE; CD4 LYMPHOCYTE PERCENTAGE; CELL KINETICS; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LYMPHOCYTE COUNT; MALE; MYELODYSPLASTIC SYNDROME; MYELOID DENDRITIC CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; T CELL LEUKEMIA;

ACUTE DISEASE; ADULT; CELL COUNT; CHRONIC DISEASE; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KINETICS; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79959541464     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2011.01300.x     Document Type: Article

References (36)

1. Abe M. & Thomson A.W. (2006) Dexamethasone preferentially suppresses plasmacytoid dendritic cell differentiation and enhances their apoptotic death. Clinical Immunology 118, 300-306.
2. Auffermann-Gretzinger S., Eger L., Bornhauser M., Schakel K., Oelschlaegel U., Schaich M., Illmer T., Thiede C. & Ehninger G. (2006) Fast appearance of donor dendritic cells in human skin: dynamics of skin and blood dendritic cells after allogeneic hematopoietic cell transplantation. Transplantation 81, 866-873.
3. Barrett A.J. & Malkovska V. (1996) Graft-versus-leukaemia: understanding and using the alloimmune response to treat haematological malignancies. British Journal of Haematology 93, 754-761.
4. Carding S.R. & Egan P.J. (2002) Gammadelta T cells: functional plasticity and heterogeneity. Nature Reviews. Immunology 2, 336-345.
5. Chakraverty R. & Sykes M. (2007) The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia. Blood 110, 9-17.
6. Clark F.J., Freeman L., Dzionek A., Schmitz J., McMullan D., Simpson P., Mason J., Mahendra P., Craddock C., Griffiths M., Moss P.A. & Chakraverty R. (2003) Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease. Transplantation 75, 221-225.
7. Colonna M., Trinchieri G. & Liu Y.J. (2004) Plasmacytoid dendritic cells in immunity. Nature Immunology 5, 1219-1226.
8. Cutler C. & Antin J.H. (2001) Peripheral blood stem cells for allogeneic transplantation: a review. Stem Cells 19, 108-117.
9. Duffner U.A., Maeda Y., Cooke K.R., Reddy P., Ordemann R., Liu C., Ferrara J.L. & Teshima T. (2004) Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. Journal of Immunology 172, 7393-7398.
10. Dzionek A., Fuchs A., Schmidt P., Cremer S., Zysk M., Miltenyi S., Buck D.W. & Schmitz J. (2000) BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. Journal of Immunology 165, 6037-6046.
11. Edinger M., Hoffmann P., Ermann J., Drago K., Fathman C.G., Strober S. & Negrin R.S. (2003) CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nature Medicine 9, 1144-1150.
12. Fallarino F., Grohmann U., Hwang K.W., Orabona C., Vacca C., Bianchi R., Belladonna M.L., Fioretti M.C., Alegre M.L. & Puccetti P. (2003) Modulation of tryptophan catabolism by regulatory T cells. Nature Immunology 4, 1206-1212.
13. Gober H.J., Kistowska M., Angman L., Jeno P., Mori L. & De Libero G. (2003) Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. The Journal of Experimental Medicine 197, 163-168.
14. Godder K.T., Henslee-Downey P.J., Mehta J., Park B.S., Chiang K.Y., Abhyankar S. & Lamb L.S. (2007) Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation. Bone Marrow Transplantation 39, 751-757.
15. Hessner M.J., Endean D.J., Casper J.T., Horowitz M.M., Keever-Taylor C.A., Roth M., Flomenberg N. & Drobyski W.R. (1995) Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia. Blood 86, 3987-3996.
16. Johnson B.D., Konkol M.C. & Truitt R.L. (2002) CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. Biology of Blood and Marrow Transplantation 8, 525-535.
17. Kalthoff F.S., Chung J., Musser P. & Stuetz A. (2003) Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids. Clinical and Experimental Immunology 133, 350-359.
18. Kunzmann V., Bauer E. & Wilhelm M. (1999) Gamma/delta T-cell stimulation by pamidronate. The New England Journal of Medicine 340, 737-738.
19. Lim H.W., Hillsamer P., Banham A.H. & Kim C.H. (2005) Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. Journal of Immunology 175, 4180-4183.
20. MacDonald K.P., Munster D.J., Clark G.J., Dzionek A., Schmitz J. & Hart D.N. (2002) Characterization of human blood dendritic cell subsets. Blood 100, 4512-4520.
21. Magenau J.M., Qin X., Tawara I., Rogers C.E., Kitko C., Schlough M., Bickley D., Braun T.M., Jang P.S., Lowler K.P., Jones D.M., Choi S.W., Reddy P., Mineishi S., Levine J.E., Ferrara J.L. & Paczesny S. (2010) Frequency of CD4(+)CD25(hi)FOXP3(+) Regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease. Biology of Blood and Marrow Transplantation 16, 907-914.
22. Molldrem J., Dermime S., Parker K., Jiang Y.Z., Mavroudis D., Hensel N., Fukushima P. & Barrett A.J. (1996) Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood 88, 2450-2457.
23. Morse M.A., Rizzieri D., Stenzel T.T., Hobeika A.C., Vredenburgh J.J., Chao N.J., Clay T.M., Mosca P.J. & Lyerly H.K. (2002) Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants. Journal of Hematotherapy & Stem Cell Research 11, 659-668.
24. Narbutt J., Lesiak A., Zak-Prelich M., Wozniacka A., Sysa-Jedrzejowska A., Tybura M., Robak T. & Smolewski P. (2004) The distribution of peripheral blood dendritic cells assayed by a new panel of anti-BDCA monoclonal antibodies in healthy representatives of the polish population. Cellular & Molecular Biology Letters 9, 497-509.
25. Porter D.L., Collins Jr R.H., Shpilberg O., Drobyski W.R., Connors J.M., Sproles A. & Antin J.H. (1999) Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions. Biology of Blood and Marrow Transplantation 5, 253-261.
26. Reddy P., Maeda Y., Liu C., Krijanovski O.I., Korngold R. & Ferrara J.L. (2005) A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nature Medicine 11, 1244-1249.
27. Rozkova D., Horvath R., Bartunkova J. & Spisek R. (2006) Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clinical Immunology 120, 260-271.
28. Saitoh A., Narita M., Watanabe N., Tochiki N., Yamahira A., Nakamura T., Kaji M., Masuko M., Furukawa T., Toba K., Fuse I., Aizawa Y. & Takahashi M. (2011) WT1 peptide vaccination in a CML patient: induction of effective cytotoxic T lymphocytes and significance of peptide administration interval. Medical Oncology 28, 219-230.
29. Saitoh A., Narita M., Watanabe N., Tochiki N., Satoh N., Takizawa J., Furukawa T., Toba K., Aizawa Y., Shinada S. & Takahashi M. (2008) Anti-tumor cytotoxicity of gammadelta T cells expanded from peripheral blood cells of patients with myeloma and lymphoma. Medical Oncology 25, 137-147.
30. Shortman K. & Naik S.H. (2007) Steady-state and inflammatory dendritic-cell development. Nature Reviews. Immunology 7, 19-30.
31. Taylor P.A., Lees C.J. & Blazar B.R. (2002) The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99, 3493-3499.
32. Vela-Ojeda J., Montiel-Cervantes L., Granados-Lara P., Reyes-Maldonado E., Garcia-Latorre E., Garcia-Chavez J., Majluf-Cruz A., Mayani H., Borbolla-Escoboza J.R. & Esparza M.G. (2010) Role of CD4+CD25+highFoxp3+ CD62L+ regulatory T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplantation. Stem Cells and Development 19, 333-340.
33. Watanabe N., Narita M., Yokoyama A., Sekiguchi A., Saito A., Tochiki N., Furukawa T., Toba K., Aizawa Y. & Takahashi M. (2006) Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate. Cytotherapy 8, 118-129.
34. Wing K. & Sakaguchi S. (2010) Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nature Immunology 11, 7-13.
35. Woltman A.M., de Fijter J.W., Kamerling S.W., Paul L.C., Daha M.R. & van Kooten C. (2000) The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. European Journal of Immunology 30, 1807-1812.
36. Wu K.N., Emmons R.V., Lisanti M.P., Farber J.L. & Witkiewicz A.K. (2009) Foxp3-expressing T regulatory cells and mast cells in acute graft-versus-host disease of the skin. Cell Cycle 8, 3593-3597.